Search research articles
Contact Us
Filters
Showing results (81-90 of 211) with videos related to
Page
of 22
Sort By:
Cancer Research
|
December 3, 2004
Proteasomal degradation of topoisomerase I is preceded by c-Jun NH2-terminal kinase activation, Fas up-regulation, and poly(ADP-ribose) polymerase cleavage in SN38-mediated cytotoxicity against multiple myeloma
Laurence Catley, Yu-Tzu Tai, Reshma Shringarpure, et al.
Cancer Research
|
February 20, 2007
Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma
Klaus Podar, Marc S Raab, Giovanni Tonon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2011
Significant biological role of sp1 transactivation in multiple myeloma
Mariateresa Fulciniti, Samir Amin, Puru Nanjappa, et al.
Cancer Research
|
July 5, 2005
Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma
Yu-Tzu Tai, Xianfeng Li, Xia Tong, et al.
Leukemia
|
August 24, 2018
APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications
Yu-Tzu Tai, Liang Lin, Lijie Xing, et al.
Blood Cancer Journal
|
August 16, 2022
γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation
Hailin Chen, Tengteng Yu, Liang Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 25, 2007
Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma
Kumar Sukhdeo, Mala Mani, Yunyu Zhang, et al.
Blood
|
November 22, 2023
ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma
Subodh Kumar, Srikanth Talluri, Jiangning Zhao, et al.
British Journal of Haematology
|
April 17, 2004
Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma
Noopur Raje, Teru Hideshima, Faith E Davies, et al.
The Journal of Biological Chemistry
|
February 11, 2005
Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation
Kip M Connor, Sita Subbaram, Kevin J Regan, et al.
Page
of 22
Search research articles
Search
Showing results (81-90 of 211) with videos related to
Sort By:
Page
of 22
Cancer Research
|
December 3, 2004
Proteasomal degradation of topoisomerase I is preceded by c-Jun NH2-terminal kinase activation, Fas up-regulation, and poly(ADP-ribose) polymerase cleavage in SN38-mediated cytotoxicity against multiple myeloma
Laurence Catley, Yu-Tzu Tai, Reshma Shringarpure, et al.
Cancer Research
|
February 20, 2007
Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma
Klaus Podar, Marc S Raab, Giovanni Tonon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2011
Significant biological role of sp1 transactivation in multiple myeloma
Mariateresa Fulciniti, Samir Amin, Puru Nanjappa, et al.
Cancer Research
|
July 5, 2005
Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma
Yu-Tzu Tai, Xianfeng Li, Xia Tong, et al.
Leukemia
|
August 24, 2018
APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications
Yu-Tzu Tai, Liang Lin, Lijie Xing, et al.
Blood Cancer Journal
|
August 16, 2022
γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation
Hailin Chen, Tengteng Yu, Liang Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 25, 2007
Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma
Kumar Sukhdeo, Mala Mani, Yunyu Zhang, et al.
Blood
|
November 22, 2023
ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma
Subodh Kumar, Srikanth Talluri, Jiangning Zhao, et al.
British Journal of Haematology
|
April 17, 2004
Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma
Noopur Raje, Teru Hideshima, Faith E Davies, et al.
The Journal of Biological Chemistry
|
February 11, 2005
Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation
Kip M Connor, Sita Subbaram, Kevin J Regan, et al.
Page
of 22